Información sobre riesgo, prevención, detección, síntomas, diagnosis, tratamiento y apoyo para el cáncer.
Información sobre el tratamiento del cáncer incluyendo quirúrgica, quimioterapia, radioterapia, estudios clínicos, terapia con protón, medicina complementaria avanzadas.
OncoLink se complace en ofrecer una amplia lista de lista completa de los agentes quimioterapéuticos más comúnmente usados??. Esta guía de referencia incluye información sobre la forma en que cada fármaco se administra, cómo funcionan, y los pacientes los efectos secundarios comunes pueden experimentar.
Maneras que los pacientes de cáncer y las personas que le cuidan puedan enfrentar el cáncer, los efectos secundarios, nutrición, cuestiones en general sobre el apoyo para el cáncer, duelo/decisiones sobre el termino de vida, y experiencias compartidas por sobrevivientes.
Tipos de Cancer / Cánceres Ginecológicos
Ultima Vez Modificado: 2 de abril del 2002
(Ephrata, PA) First Lady Kathy Schweiker, Honorary Chair of the Pennsylvania Breast Cancer Coalition (PBCC), will hold a press Conference at the University of Pennsylvania Biomedical Research Building, University of Pennsylvania Campus, Civic Center Boulevard and Osler Drive, 14th Floor, on Wednesday, April 3, 2002, at 11:30 A.M.
The First Lady is awarding the research grants from Pennsylvania's state income tax check-off for Breast and Cervical Cancer Research. Featured speakers joining Mrs. Schweiker include Pat Halpin-Murphy, PBCC President and Founder; John Glick, M.D., Director of the University of Pennsylvania Cancer Center; and Pennsylvania Secretary of Health Robert S. Zimmerman, Jr. At 11:00 AM, prior to the press conference, Mrs. Schweiker will tour a research laboratory at the Biomedical Research Building.
Landmark legislation initiated by the PBCC in 1997 established the Breast and Cervical Cancer Research Fund, which allows Pennsylvania taxpayers to donate all or part of their state tax refund to research. The average tax refund donation is $8.00. To date, nearly $1 million has been raised.
Mrs. Schweiker said, "The Income Tax Check-Off for Breast and Cervical Cancer Research is a wonderful opportunity to make a real difference in the fight against cancer by donating all or a portion of your state income tax refund to Pennsylvania's research efforts.It is especially important to note that all of the money goes to Pennsylvania-based researchers, working for the women and families of the Commonwealth to find a cure for breast and cervical cancer."
PBCC President and Founder Pat Halpin-Murphy, a breast cancer survivor, said, "Every single penny of the money raised is awarded to researchers across the state. The PBCC is a force for women and their families and the incredible success of this simple and effective way to raise research dollars renews our commitment to find a cure for breast and cervical cancer now...so our daughters won't have to." Halpin-Murphy chairs the Pennsylvania Department of Health's Cancer Control, Prevention and Research Advisory Board's Income Tax Check-Off Committee which recommends how the refund donations should be distributed.
Mrs. Schweiker will join Pennsylvania Secretary of Health Robert Zimmerman to announce the names of this year's grant recipients at the press conference.
Private donations also can be made to the research fund. To make private donations to the income tax check-off for breast and cervical cancer research, checks should be written to the Breast and Cervical Cancer Research Fund and sent to the following address: Department of Health, Bureau of Financial and Administrative Services, P.O. Box 90, Health and Welfare Building, Harrisburg, PA 17108.
The PBCC, founded in 1993, is a non-profit organization dedicated to ending the breast cancer epidemic through research, education, outreach and advocacy. As the only statewide grassroots organization that speaks to and for breast cancer survivors, the PBCC insured the passage of two crucial pieces of Commonwealth legislation:
The PBCC serves each of the Commonwealth's 67 counties through the Income Tax Check-Off, Mother's Day Mammograms®, the Keystone Breast Cancer Conference, and the photo exhibit, "67 Women, 67 Counties: Facing Breast Cancer in Pennsylvania."
For more information about the PBCC visit our website at www.pabreastcancer.org or all 717/738-9567 or toll free 1-800-377-8828.
PENN Medicine Contact:
Olivia Fermano
215.349.5653
PBCC Contact:
Bonnie Squires
610.649.0998
Commonwealth of PA Contact:
Carol Burkholder
717.738.9535
Dr. Vapiwala discusses the public awareness of prostate cancer and the public support for the disease. Read more.
Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet
Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies
Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer
Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults
OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews
Ask the Experts
Brown Bag Chat
Tracy's Corner
About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Cladribine (2-CDA, Leustatin®)
Cyclophosphamide (Cytoxan®, Neosar®, Endoxan®)
Cyclosporine (Neoral®, Sandimmune®, Restasis®, Gengraf®)
Cytarabine (Cytosar-U®, Ara-C)
Irinotecan (Camptosar®, CPT-11)
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Men
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Women
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Busulfan (Myleran®, Busulfex®)
Intravesicular Mitomycin (Mutamycin®, Mitomycin-C, given into the bladder)
Mechlorethamine (Mustargen®, Nitrogen Mustard)
mechlorethamine, mustine, Mustargen®
Megestrol (Megace®, Megace-ES®)
Mercaptopurine (Purinethol®, 6-MP)
Methotrexate (Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX)
Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX
Mitomycin (Mutamycin®, Mitomycin-C)
Morphine Sulfate (Given by IV)
Morphine Sulfate (MS Contin®, Avinza®, Kadian®, Oramorph SR®)
MS Contin®, Avinza®, Kadian®, Oramorph SR®
Mutamycin®, Mitomycin-C, given into the bladder
Nitrogen mustard (mechlorethamine, mustine, Mustargen®)
Bendamustine Hydrochloride (Treanda®)
Bexarotene (Targretin®), Oral Formulation
Bexarotene Gel (Targretin® Gel Formulation)
Etoposide (Toposar®, VePesid®, Etopophos®,VP-16)
Thioguanine (6-TG, Thioguanine Tabloid®)
Toposar®, VePesid®, Etopophos®,VP-16
Trelstar LA® and Trelstar Depot®
Tretinoin (Vesanoid®, All-Trans-Retinoic Acid, ATRA)
Triptorelin (Trelstar LA® and Trelstar Depot®)
